Literature DB >> 28351210

Expression of Pluripotency Markers in Nonpluripotent Human Neural Stem and Progenitor Cells.

Per Henrik Vincent1, Eirikur Benedikz2, Per Uhlén3, Outi Hovatta4, Erik Sundström1,5.   

Abstract

Nonpluripotent neural progenitor cells (NPCs) derived from the human fetal central nervous system were found to express a number of messenger RNA (mRNA) species associated with pluripotency, such as NANOG, REX1, and OCT4. The expression was restricted to small subpopulations of NPCs. In contrast to pluripotent stem cells, there was no coexpression of the pluripotency-associated genes studied. Although the expression of these genes rapidly declined during the in vitro differentiation of NPCs, we found no evidence that the discrete expression was associated with the markers of multipotent neural stem cells (CD133+/CD24lo), the capacity of sphere formation, or high cell proliferation rates. The rate of cell death among NPCs expressing pluripotency-associated genes was also similar to that of other NPCs. Live cell imaging showed that NANOG- and REX1-expressing NPCs continuously changed morphology, as did the nonexpressing cells. Depletion experiments showed that after the complete removal of the subpopulations of NANOG- and REX1-expressing NPCs, the expression of these genes appeared in other NPCs within a few days. The percentage of NANOG- and REX1-expressing cells returned to that observed before depletion. Our results are best explained by a model in which there is stochastic transient expression of pluripotency-associated genes in proliferating NPCs.

Entities:  

Keywords:  neural stem cells; pluripotency markers; stem cell heterogeneity

Mesh:

Substances:

Year:  2017        PMID: 28351210     DOI: 10.1089/scd.2016.0346

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  5 in total

1.  Efficient Neural Differentiation of hPSCs by Extrinsic Signals Derived from Co-cultured Neural Stem or Precursor Cells.

Authors:  Yong-Hee Rhee; Lesly Puspita; Yanuar Alan Sulistio; Seung Won Kim; Vincencius Vidyawan; Rosalie Elvira; Mi-Yoon Chang; Jae-Won Shim; Sang-Hun Lee
Journal:  Mol Ther       Date:  2019-04-17       Impact factor: 11.454

Review 2.  Stem Cell Therapies for Central Nervous System Trauma: The 4 Ws-What, When, Where, and Why.

Authors:  Xiaofei Li; Erik Sundström
Journal:  Stem Cells Transl Med       Date:  2022-03-03       Impact factor: 7.655

3.  Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets.

Authors:  Timothy Hua; Ziwei Zeng; Junji Chen; Yu Xue; Yan Li; Qingxiang Sang
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

4.  P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma.

Authors:  Vanessa Fernandes Arnaud-Sampaio; Carolina Adriane Bento; Talita Glaser; Elena Adinolfi; Henning Ulrich; Claudiana Lameu
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

Review 5.  Molecular Mechanisms of Transdifferentiation of Adipose-Derived Stem Cells into Neural Cells: Current Status and Perspectives.

Authors:  Liang Luo; Da-Hai Hu; James Q Yin; Ru-Xiang Xu
Journal:  Stem Cells Int       Date:  2018-09-13       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.